Stem cells at school, plus new fact sheets on EuroStemCell
Posted by Emma Kemp, on 29 January 2013
Happy 2013 everyone! I hope you’re all settling into the year nicely.We sent out our EuroStemCell January newsletter last week and I thought some of you might be interested in our latest schools activities and fact sheets on stem cell research.
Highlights this month include a new lesson for 12-14 year olds on Stem cell treatments and ethics and a blog from Cambridge Stem Cell Institute researchers about their successful school visit using our CSI: Cell science investigators lesson.
Our collection of fact sheets is always growing: the latest additions are on (1) Umbilical cord blood and stem cells and (2) the role of commercial organisations in developing stem cell treatments. We’ve also added more fact sheet translations – most recently into French, Spanish and Italian.
Remember: you can stay in touch inbetween newsletters by following @eurostemcell on Twitter or liking us on Facebook. Your feedback is always very welcome – via these channels or use our contact form to get in touch.
(2 votes)
Loading...
Hey guys, love the resources. Wondering if you’ve ever covered Rongxiang Xu? He’s the Chinese stem cell researcher suing the Nobel Assembly.
I’d love to find out.
Hi Daniel,
Thanks for getting in touch, glad you like our resources. Have you used any of them? We’d love to get your feedback on what you like or think we could do better.
We haven’t covered the Xu story and don’t currently have any plans to do so. Sorry not to be able to help on that.
Emma
Hi Daniel,
Emma already spoke for EuroStemCell, but this *might* be something we’d consider covering on the Node in general.
The only problem is that there factually *isn’t* much to write about. Your comment says it all, really: he sued the Nobel Assembly, the assembly said they didn’t know him, and nothing seems to have happened after that. It’s a bit hard for us (at the Node) to write about with so little info, but if a researcher in the field wanted to write an opinion post about it, and focus on the papers and patents that are in question, they’re more than welcome to!